Matches in SemOpenAlex for { <https://semopenalex.org/work/W3181640034> ?p ?o ?g. }
- W3181640034 abstract "Abstract Background Mesenchymal stem cells (MSCs) have received particular attention because of their ability to modulate the immune system and inhibit inflammation caused by cytokine storms due to SARS-CoV-2. New alternative therapies may reduce mortality rates in patients with COVID19. This study aimed to assess the safety and efficacy of injecting intravenous Wharton’s jelly-derived MSCs in patients with COVID-19 as a treatment. Methods In this study, five patients with severe COVID-19 were treated with Wharton’s jelly-derived mesenchymal stem cells (150 × 106 cells per injection). These patients were subject to three intravenous injections 3 days apart, and monitoring was done on days 0, 3, 6, and 14 in routine tests, inflammatory cytokines, and flow cytometry of CD4 and CD8 markers. A lung CT scan was performed on base and days 14 and 28. In addition, IgM and IgG antibodies against SARS-CoV-2 were measured before and after treatment. Results The results showed that IL-10 and SDF-1 increased after cell therapy, but VEGF, TGF-β, IFN-γ, IL-6, and TNFα decreased. Routine hematology tests, myocardial enzyme tests, biochemical tests, and inflammation tests were performed for all patients before and after cell therapy on base and days 3, 6, and 14, which indicated the improvement of test results over time. COVID-19 antibody tests rose in 14 days after WJ-MSC injection. The total score of zonal involvement in both lungs was improved. Conclusions In patients, the trend of tests was generally improving, and we experienced a reduction in inflammation. No serious complications were observed in patients except the headache in one of them, which was resolved without medication. In this study, we found that patients with severe COVID-19 in the inflammatory phase respond better to cell therapy. More extensive clinical trials should be performed in this regard. Trial registration IRCT, IRCT20190717044241N2. Registered April 22, 2020." @default.
- W3181640034 created "2021-07-19" @default.
- W3181640034 creator A5000909347 @default.
- W3181640034 creator A5010706645 @default.
- W3181640034 creator A5012837803 @default.
- W3181640034 creator A5028736652 @default.
- W3181640034 creator A5030493941 @default.
- W3181640034 creator A5032755875 @default.
- W3181640034 creator A5033480938 @default.
- W3181640034 creator A5046058229 @default.
- W3181640034 creator A5081502359 @default.
- W3181640034 creator A5084584061 @default.
- W3181640034 creator A5085262935 @default.
- W3181640034 creator A5086976721 @default.
- W3181640034 creator A5087662144 @default.
- W3181640034 creator A5088314873 @default.
- W3181640034 date "2021-07-16" @default.
- W3181640034 modified "2023-10-06" @default.
- W3181640034 title "Cell therapy in patients with COVID-19 using Wharton’s jelly mesenchymal stem cells: a phase 1 clinical trial" @default.
- W3181640034 cites W1494355500 @default.
- W3181640034 cites W1516256623 @default.
- W3181640034 cites W198903736 @default.
- W3181640034 cites W2031812779 @default.
- W3181640034 cites W2038745583 @default.
- W3181640034 cites W2045287986 @default.
- W3181640034 cites W2073018806 @default.
- W3181640034 cites W2073024911 @default.
- W3181640034 cites W2076396596 @default.
- W3181640034 cites W2076414869 @default.
- W3181640034 cites W2095666785 @default.
- W3181640034 cites W2098636563 @default.
- W3181640034 cites W2117412164 @default.
- W3181640034 cites W2122083530 @default.
- W3181640034 cites W2128382826 @default.
- W3181640034 cites W2130158896 @default.
- W3181640034 cites W2146069187 @default.
- W3181640034 cites W2153949260 @default.
- W3181640034 cites W2161006376 @default.
- W3181640034 cites W2167384912 @default.
- W3181640034 cites W2230319261 @default.
- W3181640034 cites W2238141562 @default.
- W3181640034 cites W2341518345 @default.
- W3181640034 cites W2531243522 @default.
- W3181640034 cites W2550149750 @default.
- W3181640034 cites W2605484523 @default.
- W3181640034 cites W2613953612 @default.
- W3181640034 cites W2727272993 @default.
- W3181640034 cites W2793525827 @default.
- W3181640034 cites W2805892376 @default.
- W3181640034 cites W2810735970 @default.
- W3181640034 cites W2943233832 @default.
- W3181640034 cites W2946450286 @default.
- W3181640034 cites W2999364275 @default.
- W3181640034 cites W3001118548 @default.
- W3181640034 cites W3002533507 @default.
- W3181640034 cites W3004280078 @default.
- W3181640034 cites W3004318991 @default.
- W3181640034 cites W3005656138 @default.
- W3181640034 cites W3007273493 @default.
- W3181640034 cites W3010434344 @default.
- W3181640034 cites W3011568661 @default.
- W3181640034 cites W3011812996 @default.
- W3181640034 cites W3012115598 @default.
- W3181640034 cites W3013231340 @default.
- W3181640034 cites W3015228903 @default.
- W3181640034 cites W3016955027 @default.
- W3181640034 cites W3030808334 @default.
- W3181640034 cites W3032142764 @default.
- W3181640034 cites W3036989676 @default.
- W3181640034 cites W3087385265 @default.
- W3181640034 cites W3113773386 @default.
- W3181640034 cites W3123599371 @default.
- W3181640034 cites W4205623043 @default.
- W3181640034 doi "https://doi.org/10.1186/s13287-021-02483-7" @default.
- W3181640034 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8283394" @default.
- W3181640034 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34271988" @default.
- W3181640034 hasPublicationYear "2021" @default.
- W3181640034 type Work @default.
- W3181640034 sameAs 3181640034 @default.
- W3181640034 citedByCount "49" @default.
- W3181640034 countsByYear W31816400342021 @default.
- W3181640034 countsByYear W31816400342022 @default.
- W3181640034 countsByYear W31816400342023 @default.
- W3181640034 crossrefType "journal-article" @default.
- W3181640034 hasAuthorship W3181640034A5000909347 @default.
- W3181640034 hasAuthorship W3181640034A5010706645 @default.
- W3181640034 hasAuthorship W3181640034A5012837803 @default.
- W3181640034 hasAuthorship W3181640034A5028736652 @default.
- W3181640034 hasAuthorship W3181640034A5030493941 @default.
- W3181640034 hasAuthorship W3181640034A5032755875 @default.
- W3181640034 hasAuthorship W3181640034A5033480938 @default.
- W3181640034 hasAuthorship W3181640034A5046058229 @default.
- W3181640034 hasAuthorship W3181640034A5081502359 @default.
- W3181640034 hasAuthorship W3181640034A5084584061 @default.
- W3181640034 hasAuthorship W3181640034A5085262935 @default.
- W3181640034 hasAuthorship W3181640034A5086976721 @default.
- W3181640034 hasAuthorship W3181640034A5087662144 @default.
- W3181640034 hasAuthorship W3181640034A5088314873 @default.
- W3181640034 hasBestOaLocation W31816400341 @default.
- W3181640034 hasConcept C10882517 @default.